Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Revenue (2020 - 2025)

Historic Revenue for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $260000.0.

  • Insight Molecular Diagnostics' Revenue rose 12608.7% to $260000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 52087.45%. This contributed to the annual value of $1.9 million for FY2024, which is 2514.97% up from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Revenue is $260000.0, which was up 12608.7% from $518000.0 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Revenue ranged from a high of $3.6 million in Q4 2021 and a low of $67000.0 during Q3 2022
  • For the 5-year period, Insight Molecular Diagnostics' Revenue averaged around $843631.6, with its median value being $429000.0 (2023).
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Revenue soared by 692500.0% in 2021, and later crashed by 9319.11% in 2022.
  • Insight Molecular Diagnostics' Revenue (Quarter) stood at $3.6 million in 2021, then plummeted by 92.37% to $274000.0 in 2022, then increased by 14.6% to $314000.0 in 2023, then surged by 373.25% to $1.5 million in 2024, then tumbled by 82.5% to $260000.0 in 2025.
  • Its last three reported values are $260000.0 in Q3 2025, $518000.0 for Q2 2025, and $2.1 million during Q1 2025.